CD56(bright) natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results

Randomized trials have conclusively shown higher rates of chronic graft-versus-host disease with filgrastim-stimulated apheresis peripheral blood as a donor source than unstimulated bone marrow. The Canadian Blood and Marrow Transplant Group conducted a phase 3 study of adults who received either fi...

全面介紹

Na minha lista:
書目詳細資料
發表在:Haematologica
Main Authors: Kariminia, Amina, Ivison, Sabine, Ng, Bernard, Rozmus, Jacob, Sung, Susanna, Varshney, Avani, Aljurf, Mahmoud, Lachance, Sylvie, Walker, Irwin, Toze, Cindy, Lipton, Jeff, Lee, Stephanie J., Szer, Jeff, Doocey, Richard, Lewis, Ian, Smith, Clayton, Chaudhri, Naeem, Levings, Megan K., Broady, Raewyn, Devins, Gerald, Szwajcer, David, Foley, Ronan, Mostafavi, Sara, Pavletic, Steven, Wall, Donna A., Couban, Stephan, Panzarella, Tony, Schultz, Kirk R.
格式: Artigo
語言:Inglês
出版: Ferrata Storti Foundation 2017
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5664398/
https://ncbi.nlm.nih.gov/pubmed/28935847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.170928
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍